Nootropic preparation "Anvifen": instructions for use

The drug "Anvifen" instructions for use characterizes as a nootropic agent, which has an antioxidant, antiaggregant, tranquilizing and moderate anticonvulsant effect. Regular intake of this drug can reduce vascular resistance, improve microcirculation and functional state of the brain, activate cerebral blood flow, normalize metabolic processes, reduce the severity of nystagmus and extend the latent period. In addition, the nootropic drug "Anvifen" (the instructions for use emphasizes this special attention) has a pronounced antiaggregant effect, increases mental and physical performance (the accuracy of the so-called sensory motor reactions, memory, attention). At the same time, this drug is based on the relief of GABA-mediated transmission of nerve impulses directly in the central nervous system due to direct action on GABA-ergic type receptors.

Thanks to this process, the medicine effectively reduces anxiety, improves overall health, relieves headache, normalizes sleep, reduces emotional lability, asthenia, and irritability.

Produced nootropic drug "Anvifen" in the form of hard gelatin capsules. Each tablet contains aminophenylbutyric acid hydrochloride in the amount of 25, 50, 125 or 250 milligrams as an active ingredient. Additional components are lactose, giprolase, silicon dioxide and magnesium stearate.

Take capsules "Anvifen" instructions for use, attached by the manufacturer, recommends for the treatment of patients suffering from various anxiety-neurotic and asthenic conditions. With increased nighttime anxiety and insomnia, the elderly are also indicated for the purpose of this nootropic remedy. In addition, it should be taken to children with enuresis, stuttering or ticking.

In Meniere's disease, it is also recommended to start taking Anvifen capsules. Instructions for use advise to appoint them in the case of dizziness associated with abnormalities in the vestibular analyzer. In addition to all the above, this nootropic remedy is absolutely indispensable in the complex treatment of alcohol withdrawal syndrome (to eliminate somatovegetative and psychopathological disorders) and prevention of motion sickness with kinetosis.

It is strictly forbidden to prescribe the drug "Anvifen" for women who carry a child, children under the age of three, and people with an individual intolerance to aminophenylbutyric acid. In addition, do not use this nootropic drug in the lactation period and in case of an allergic reaction to any auxiliary substances contained in its composition. People with erosive and ulcerative lesions of the gastrointestinal tract are also advised to refrain from taking the drug "Anvifen". The doctors' testimonies also testify to the undesirability of its use by patients with severe hepatic insufficiency.